ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

VEC Vectura Group Plc

164.80
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vectura Group Plc LSE:VEC London Ordinary Share GB00BKM2MW97 ORD 0.0271P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 164.80 164.80 165.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Vectura Share Discussion Threads

Showing 6176 to 6200 of 12050 messages
Chat Pages: Latest  254  253  252  251  250  249  248  247  246  245  244  243  Older
DateSubjectAuthorDiscuss
27/10/2017
13:51
Yes arrived here allso by skp I THOUGHT With THE POTENTIAL Of FLUITFORM AND THE Generic Copy TO Name But TWO THERE Seemed POTENTIAL.
IT AS TURNED OUT DISSAPOINTING BUT AT ONE POINT MANY YEARS AGO BEFORE SEVERAL AVERAGING DOWNS I WAS LOSING 50/60 THOUSAND IN SKP AND LOOK AT THE RUN UP WE ENJOYED THERE. Vectura has been a big dissapointment for sure but feel it can only be upside from here PATIENCE IS THE GAME.

best1467
27/10/2017
11:59
Also lth in SKP now Vec sold half my holding last year and promised myself would sell the rest if it breached 100p, still here. To be honest I was heartened by the more upbeat view of the prospects of the Advair generic then the director buys. We are due to hear, this year about "the regulatory timetable" for VR 315, so may just give it until year end.
diesel
27/10/2017
11:10
Yes in Bormes less Mimosa for last 5 weeks weather superb 26c at the moment but back to reality on Tuesday, NOVEMBER in the cotswolds not quite the same,
pooroldboy55
27/10/2017
09:57
Similar POB, suffered for years with SKP only to have the pain transferred to VEC just when SKP were starting to look good! Still well in profit here but BOD seem to be doing their best to change that. Also in LLOY.

If I remember correctly you were in SOF recently. If we get to over £2 here (which I was expecting by now) then I plan to spend a lot of my time there myself. Seems a long way off at the moment though.

gbcol
27/10/2017
09:25
Gcol no I haven't I'm very lucky my buy in price via SKP only 73/74p still have 40000 plus 2000 from a few weeks back at 92ish had nearly 90000 my last sell was 153p so not all bad news my biggest holding by a long way is Lloyds Bank and at the moment seems ok
POB

pooroldboy55
27/10/2017
09:05
Does anyone know whatever became of Vectura's Chinese joint venture Kinnovata? It kicked off back in 2013, but it's all gone a bit quiet since then...http://www.vectura.com/news/vectura-establishes-strategic-partnership-kinnovata-new-respiratory-business-china/
saxula
27/10/2017
09:01
POB have you written to their Investor Relations team to express your concerns? I have on two occasions this year, where I have expressed my great concerns at the share price falls since the takeover, an the effect that has had on my retirement plans! I have also suggested they consider share buybacks (which I think would be very beneficial). They have said they have no plans for buybacks BTW.

At least if shareholders contact them they will get some direct feedback - I doubt they spend too much time reading these bulletin boards.

gbcol
27/10/2017
08:46
Looks like big down again today, what I don't understand no comments on share price from B OF DIRECTOR'S. you think when the price as almost halfed in twelve months they might say something.
Back in the UK next week after 5 weeks away with the wife so no more depressing post from me till end of year.
cheers POB

pooroldboy55
25/10/2017
11:01
Sorry wrong board ! Ignore the above.
dp1umb
25/10/2017
09:30
Maybe my 32p by year end isn't that far off the mark? Although if I was betting against 11%'s 25p then at this stage I would take his 25p.
dp1umb
24/10/2017
18:06
Now trading around book price which is 96p. Like all drug companies it does carry a large amount of intangibles/goodwill. Cash balance was unchanged at H1 = £91M. Adjusted EBITDA H1 £19M
justiceforthemany
24/10/2017
16:58
Injectables was not sold to fund fluitform it was they had to choose between the two and fluitform was further down the pipeline,And sorry but more bad news The royalties end in 2017/18 financial year end from Pacira and I'm suffering pain there they have hit a two year low this week.
best1467
24/10/2017
15:03
first daily close below £1 me thinks. opens the door to a retest of the 90p support. or lack of whichever. bounced well last time from £1 but not today!

take your time baby, don't drop too quickly. i need get some funds ready.

citytrader66
24/10/2017
14:20
Damn that predictive spelling!
fhmktg
24/10/2017
14:15
It's been a terrific story and will be a feature in anaesthesia for many years.Shame it had to be sold to fun's Flutiform.Not sure when the agreement with Pacira terminates?
fhmktg
24/10/2017
12:30
Some more moderately good news last week, VEC receives 3% of sales, plus another $32m milestone payment when this hits $500m annual sales:
rogerrail
24/10/2017
12:10
1.5% out for short but no change on that in a month...
rathean
24/10/2017
10:29
So how do we account for rise on Friday? anyone know what the short position is.
pooroldboy55
24/10/2017
09:47
You're right prob; google Vectura peg ratio to get the lose data.Not much there to enthuse.
fhmktg
24/10/2017
09:28
Hi fumktg just out of interest how many companies have assets worth more than there share price I have never looked at this perhaps I should
cheers POB

pooroldboy55
24/10/2017
09:09
fhmktg-completely agree, we need some favourable progress on Advair and the court case to get some significant movement in the share price otherwise it's a wait for a couple of years. Today's news of growth of 6% and 0% is not exactly inspiring but, hopefully, next year will be much better with US sales in the numbers.
alexchry
24/10/2017
08:53
If you peruse the financials section there isn't much to be enthusiastic about, with net assets just about matching the share price Two significant downsides this year with the failure to get into the Advair market and the legal shenanigans.Flutiform should keep the wolf from the door for now and the Novartis franchise holds some growth potential.But without a steady and sustained stream of successful developments there is no reason for new investors to come in.2019/20 is a long wait.
fhmktg
24/10/2017
08:48
Just wait till we get some bad news! !!!!!!!!. well someone sure knows something and it's not us.
pooroldboy55
24/10/2017
08:45
Maybe just bad mgt and the market does not like this? All imho of course!
dunderheed
24/10/2017
08:37
Sentimen for Vectura so negative - even good news sending share price down .
May be shorters know more than ourselves.

a1ord53
Chat Pages: Latest  254  253  252  251  250  249  248  247  246  245  244  243  Older

Your Recent History

Delayed Upgrade Clock